The Transfer and Stable Integration of the HSV Thymidine Kinase Gene into Mouse Cells
Overview
Authors
Affiliations
Treatment of mutant mouse cells (Ltk-) deficient in thymidine kinase with Bam I restriction endonuclease-cleaved HSV-1 DNA results in the appearance of numerous surviving colonies which stably express thte tk+ phenotype. Through a series of electrophoretic fractionations in concert with transfection assays, we isolated a 3.4 kb fragment which contains the thymidine kinase gene and which alone is competent in the biochemical transformation of Ltk- cells. In this report, we have examined the distribution of tk sequences in the DNA of several transformed clones following stable gene transfer. A series of complementary experiments involving reassociation kinetics in solution and annealings with tk DNA to restriction-cleaved cellular DNA following electrophoresis and transfer to filters allow us to make the following general conclusions concerning the fate of the tk gene in all clones examined: the tk gene is present in all cells at a frequency of one copy per chromosomal complement; the tk gene is stably integrated in the DNA of all transformants; and integration is not site-specific and occurs at different loci in the DNA of all transformants examined. The existence of a single active tk gene in tk+ transformants now facilitates an analysis of the sequence organization of tk- mutant cells and provides a useful model system for studies on the transfer of cellular genes.
Silencing of Unintegrated Retroviral DNAs.
Goff S Viruses. 2021; 13(11).
PMID: 34835055 PMC: 8621569. DOI: 10.3390/v13112248.
Liao Y, Bajwa K, Reddy S, Lupiani B Microorganisms. 2021; 9(6).
PMID: 34200544 PMC: 8228275. DOI: 10.3390/microorganisms9061260.
"Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.
Dogrammatzis C, Waisner H, Kalamvoki M Viruses. 2020; 13(1).
PMID: 33374862 PMC: 7824580. DOI: 10.3390/v13010017.
Xie Y, Wu L, Wang M, Cheng A, Yang Q, Wu Y Front Microbiol. 2019; 10:941.
PMID: 31134006 PMC: 6517553. DOI: 10.3389/fmicb.2019.00941.
Current and future alternative therapies for beta-thalassemia major.
de Dreuzy E, Bhukhai K, Leboulch P, Payen E Biomed J. 2016; 39(1):24-38.
PMID: 27105596 PMC: 6138429. DOI: 10.1016/j.bj.2015.10.001.